Psychiatric Disorders and Psychopharmacology

This track delves into the complex neurobiology of psychiatric illnesses, including depression, bipolar disorder, anxiety, schizophrenia, and PTSD. Attendees will explore how imbalances in neurotransmitter systems such as serotonin, dopamine, and norepinephrine influence mood and behaviour. Psychopharmacology sessions will focus on the development and clinical use of antidepressants, antipsychotics, mood stabilizers, and anxiolytics. The track will highlight recent advancements in pharmacogenomics, personalized medicine, and the role of neuroinflammation in psychiatric pathology. Cutting-edge research on psychedelic-assisted therapy and novel targets like ketamine will also be presented. This track is vital for anyone interested in the evolving landscape of mental health treatment.

    Related Conference of Psychiatric Disorders and Psychopharmacology

    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore

    Psychiatric Disorders and Psychopharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in